Jaan Biotherapeutics, LLC is a private company based in San Diego, CA, that is dedicated to developing innovative therapies for cardiovascular diseases. Their proprietary technology manipulates microRNAs to activate the natural cardiac muscle regeneration process in diseased hearts, with a particular focus on Ischemic Heart Disease (IHD) and other cardiac conditions requiring muscle regeneration, such as cardiomyopathy associated with Duchenne Muscular Dystrophy (DMD) and hypertrophic cardiomyopathy (HCM).
With over 30 patents, including five US issued patents, Jaan Biotherapeutics is at the forefront of drug design and targets in the field. Their goal is to initiate clinical testing for their lead programs in 2025, and they have received three National Institutes of Health Small Business grants to support their drug development pipeline since 2017.
Generated from the website
